PhD-forsvar Alexander S. Christensen

​This week Alexander Sidelmann Christensen, MD, was awarded the PhD title after an elegant defence of the thesis "Incretin-based therapy as add-on to sulfonylurea in patients with hepatocyte nuclear factor 1-alpha diabetes; based on publications which have already changed the way many clinicians treat HNF1A-diabetes: https://pubmed.ncbi.nlm.nih.gov/32661107/ and https://pubmed.ncbi.nlm.nih.gov/32518064.

Redaktør